ALMI Invest invests SEK 4 million

Almi Invest is investing four million kronor in Moroxite F for developing a new treatment for osteoporosis. Fåhraeus Startup & Growth is also participating in the issue of a total of ten million kronor. The money will be used to carry out the first clinical studies.

Thanks to this investment, we can take the next step in our development and seriously start preliminary clinical studies while simultaneously mapping the regulatory process for our method, says Semmy Rülf, Chairman of the Board of Moroxite F.

About Almi Invest

Almi Invest is Sweden's most active investor in startups. We make investments throughout the country through 8 regional venture capital companies and one national venture capital company within GreenTech. Almi Invest manages approximately SEK 3.5 billion and has since its inception invested in approximately 660 startups. Our best holdings have been acquired by, among others, Google, Microsoft, Qlik and Apple or listed on various stock exchanges. Almi Invest is a venture capital company within the Almi Group and part-financed by the EU's structural funds.